Resultados de la búsqueda 1-10 of 1413 for ���������������������������op������r���:za33���

1. Untitled

   Page 1.

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... (R/R) MM. ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.

6. Untitled

   Page 1.

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... (R/R) multiple myeloma (MM). Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... (R/R) MM. ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... (R/R) chronic lymphocytic leukemia (CLL). MC1733, Phase I Trial of Intratumoral Administration of a Measles Virus Derivative Expressing the Helicobacter ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... (R/R) multiple myeloma (MM). Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL ...